91 results
424B5
RVMD
Revolution Medicines, Inc.
7 Aug 24
Prospectus supplement for primary offering
5:07pm
prepared by or on behalf of us or to which we have referred you. We and TD Cowen take no responsibility for, and can provide no assurance … be no assurance that we will be able to sell any shares under or fully utilize the sales agreement with TD Cowen as a source of financing.
We intend
S-3ASR
5zil0w
8 May 24
Automatic shelf registration
5:11pm
S-3ASR
s5g93jar h9rr877gzgs
4 Mar 24
Automatic shelf registration
5:23pm
DEFM14A
skn6ewu7pf3y5
29 Sep 23
Proxy related to merger
4:19pm
424B3
qe6 huvowf0soz
29 Sep 23
Prospectus supplement
4:17pm